Giovanni Capranico

7.5k total citations
144 papers, 6.2k citations indexed

About

Giovanni Capranico is a scholar working on Molecular Biology, Oncology and Toxicology. According to data from OpenAlex, Giovanni Capranico has authored 144 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 134 papers in Molecular Biology, 53 papers in Oncology and 33 papers in Toxicology. Recurrent topics in Giovanni Capranico's work include Cancer therapeutics and mechanisms (109 papers), DNA and Nucleic Acid Chemistry (49 papers) and Bioactive Compounds and Antitumor Agents (33 papers). Giovanni Capranico is often cited by papers focused on Cancer therapeutics and mechanisms (109 papers), DNA and Nucleic Acid Chemistry (49 papers) and Bioactive Compounds and Antitumor Agents (33 papers). Giovanni Capranico collaborates with scholars based in Italy, United States and Netherlands. Giovanni Capranico's co-authors include Franco Zunino, Jessica Marinello, Yves Pommier, Kurt W. Kohn, Monica Binaschi, Stella Tinelli, Manlio Palumbo, Marco Russo, Stefano Giustino Manzo and Olivier Sordet and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Giovanni Capranico

143 papers receiving 6.1k citations

Peers

Countries citing papers authored by Giovanni Capranico

Since Specialization

Citations

This map shows the geographic impact of Giovanni Capranico's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giovanni Capranico with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giovanni Capranico more than expected).

Fields of papers citing papers by Giovanni Capranico

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giovanni Capranico. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giovanni Capranico. The network helps show where Giovanni Capranico may publish in the future.

Co-authorship network of co-authors of Giovanni Capranico

This figure shows the co-authorship network connecting the top 25 collaborators of Giovanni Capranico. A scholar is included among the top collaborators of Giovanni Capranico based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giovanni Capranico. Giovanni Capranico is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genomic context influences translesion synthesis DNA polymerase-dependent mechanisms of micronuclei induction by G-quadruplexes 2025 ·Cell Reports ·(unknown), Federico Guerra, Marco Russo, (unknown), Giovanni Capranico	1
2	Human DNA topoisomerase I poisoning causes R loop–mediated genome instability attenuated by transcription factor IIS 2024 ·Science Advances ·(unknown), Jessica Marinello, Marco Russo, (unknown), (unknown), (unknown), Belén Gómez‐González, Andrés Aguilera, Giovanni Capranico	14
3	Stimulation of cGAS-STING pathway as a challenge in the treatment of small cell lung cancer: a feasible strategy? 2024 ·British Journal of Cancer ·Giulia Miglietta, Marco Russo, Giovanni Capranico, Jessica Marinello	2
4	Immunofluorescence microscopy of G-quadruplexes and R-loops 2024 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Giulia Miglietta, Jessica Marinello, Giovanni Capranico	2
5	MYCN Amplification, along with Wild-Type RB1 Expression, Enhances CDK4/6 Inhibitors’ Efficacy in Neuroblastoma Cells 2023 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), Marco Russo, (unknown), (unknown), Giovanni Capranico, Giorgio Milazzo, Giovanni Perini	1
6	Topoisomerase I poison-triggered immune gene activation is markedly reduced in human small-cell lung cancers by impairment of the cGAS/STING pathway 2022 ·British Journal of Cancer ·Jessica Marinello, (unknown), Marco Russo, (unknown), Francesca D. Ciccarelli, Yves Pommier, Giovanni Capranico	34
7	Highly Purified Top1-Bound DNA Fragments 2022 ·Methods in molecular biology ·Jessica Marinello, Giovanni Capranico	1
8	G-quadruplex binders as cytostatic modulators of innate immune genes in cancer cells 2021 ·Nucleic Acids Research ·Giulia Miglietta, Marco Russo, (unknown), Giovanni Capranico	39
9	DNA damage and genome instability by G-quadruplex ligands are mediated by R loops in human cancer cells 2018 ·Proceedings of the National Academy of Sciences ·Alessio De Magis, Stefano Giustino Manzo, Marco Russo, Jessica Marinello, Rita Morigi, Olivier Sordet, Giovanni Capranico	227
10	DNA Topoisomerase I differentially modulates R-loops across the human genome 2018 ·Genome biology ·Stefano Giustino Manzo, Stella R. Hartono, Lionel A. Sanz, Jessica Marinello, Sara De Biasi, Andrea Cossarizza, Giovanni Capranico, Frédéric Chédin	110
11	Mapping DNA Breaks by Next-Generation Sequencing 2017 ·Methods in molecular biology ·Laura Baranello, Fedor Kouzine, Damian Wójtowicz, Kairong Cui, Keji Zhao, Teresa M. Przytycka, Giovanni Capranico, David Levens	6
12	Naphthoquinone Derivatives Exert Their Antitrypanosomal Activity via a Multi-Target Mechanism 2013 ·PLoS neglected tropical diseases ·Stefano Pieretti, Jurgen R. Haanstra, Muriel Mazet, Remo Perozzo, Christian Bergamini, Federica Prati, Romana Fato, Giorgio Lenaz, Giovanni Capranico, Reto Brun, Barbara M. Bakker, Paul A.M. Michels, Léonardo Scapozza, María Laura Bolognesi, Andrea Cavalli	89
13	Natural Product Triptolide Mediates Cancer Cell Death by Triggering CDK7-Dependent Degradation of RNA Polymerase II 2012 ·Cancer Research ·Stefano Giustino Manzo, Zhaoli Zhou, Ying-Qing Wang, Jessica Marinello, Qingli He, Yuanchao Li, Jian Ding, Giovanni Capranico, Ze‐Hong Miao	94
14	Intracellular Distribution ofβ-Catenin in Human Medulloblastoma Cell Lines with Different Degree of Neuronal Differentiation 2007 ·Ultrastructural Pathology ·Roberta Salaroli, Alessandra Russo, Claudio Ceccarelli, (unknown), Antonietta Arcella, Giuseppe Martinelli, Felice Giangaspero, Giovanni Capranico, Giovanna Cenacchi	5
15	Configurational requirements of the sugar moiety for the pharmacological activity of anthracycline disaccharides 1999 ·Biochemical Pharmacology ·Federico Arcamone, Fabio Animati, Mario Bigioni, Giovanni Capranico, Claudia Caserini, Amalia Cipollone, Michelandrea De Cesare, (unknown), (unknown), Stefano Manzini, Edith Monteagudo, Graziella Pratesi, (unknown), Rosanna Supino, Franco Zunino	25
16	Drug sensitivity and sequence specificity of human recombinant DNA topoisomerases IIα (p170) and IIβ (p180) 1996 ·Molecular Pharmacology ·(unknown), (unknown), Elaine Willmore, (unknown), L. Mark Fisher, Caroline A. Austin, Giovanni Capranico	14
17	Base mutation analysis of topoisomerase II-idarubicin-DNA ternary complex formation. Evidence for enzyme subunit cooperativity in DNA cleavage 1994 ·Nucleic Acids Research ·Mario Bigioni, Franco Zunino, Giovanni Capranico	24
18	Similar sequence specificity of mitoxantrone and VM-26 stimulation of in vitro DNA cleavage by mammalian DNA topoisomerase II 1993 ·Biochemistry ·Giovanni Capranico, (unknown), Stella Tinelli, Mario Bigioni, Franco Zunino	54
19	Multidrug sensitivity phenotype of human lung cancer cells associated with topoisomerase II expression. 1992 ·PubMed ·Giuseppe Giaccone, Adi F. Gazdar, Hans L. M. Beck, Franco Zunino, Giovanni Capranico	119
20	Local sequence requirements for DNA cleavage by mammalian topoisomerase II in the presence of doxorubicin 1990 ·Nucleic Acids Research ·Giovanni Capranico, Kurt W. Kohn, Yves Pommier	159

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact